Biochemical Engineering Special Interest Group
biological engineering professionals
14 March 2016

Cambridge Epigenetix announces $21M Series B financing

Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, today announced the close of a $21 million Series B financing and the appointment of Dr. Geoff Smith as CEO. The round was led by GV (formerly Google Ventures), with significant participation from Sequoia Capital, New Science Ventures, Syncona Partners and Cambridge University. In conjunction with the fundraising, Tom Hulme, GV general partner, will join CEGX's board of directors and co-founder Dr. Bobby Yerramilli-Rao will assume the role of Chairman. Source: Fierce Biotech 14/3/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).